ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,025,000 | -40.6% | 700,000 | +40.0% | 2.13% | -15.0% |
| Q3 2018 | $6,780,000 | -18.4% | 500,000 | -28.6% | 2.51% | -14.3% |
| Q2 2018 | $8,309,000 | +85.0% | 700,000 | +75.0% | 2.93% | +95.9% |
| Q1 2018 | $4,492,000 | -47.7% | 400,000 | -62.1% | 1.49% | -74.6% |
| Q2 2016 | $8,597,000 | -40.0% | 1,054,864 | -40.1% | 5.88% | -16.2% |
| Q1 2016 | $14,322,000 | -32.6% | 1,761,567 | 0.0% | 7.01% | -1.6% |
| Q4 2015 | $21,244,000 | +1.0% | 1,761,567 | +0.2% | 7.12% | +11.5% |
| Q3 2015 | $21,034,000 | -34.7% | 1,757,268 | 0.0% | 6.39% | -43.5% |
| Q2 2015 | $32,211,000 | – | 1,757,268 | – | 11.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
| Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
| NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
| PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
| GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
| Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
| Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
| Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
| AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
| Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |